Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Glaukos Corporation
The US Medicare agency's new rule for facility fees brings more bad news for Glaukos; Wells Fargo downgrades company’s stock in response.
The US Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes new reimbursement levels for multiple medical devices, including the Glaukos iStent.
A proposed change to US Medicare billing that would go into effect 1 January might give one manufacturer an edge over its competitor.
Keeping Track: First COVID Vaccine BLA Kicks Off; Oncology Submissions From Hutchmed, Takeda And Shorla
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker